AMMJ · As filed with the SEC

American Cannabis Company cash flow statement, by quarter

The statement as American Cannabis Company presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) · USD

USDQ2 2024†
3 months ended Jun 30, 2024
Q1 2024
3 months ended Mar 31, 2024
Q4 2023†
3 months ended Dec 31, 2023
Q3 2023†
3 months ended Sep 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Profit or Loss(636,171)†(132,551)—(127,160)†
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation Expense60,113†71,554—60,118†
Changes in operating assets and liabilities:
Accounts receivable(15,894)†113,600(31,843)†90,817†
Inventory404,153†(83,720)(67,918)†(9,999)†
Prepaid expenses and other current assets2,902†41,87914,899†13,893†
Right of Use Lease Asset—46,243——
Accounts payable109,951†59,48375,720†125,650†
Advances from Clients——107,147†—
Advances from clients(10,446)†(112,922)——
Accrued and other current liabilities44,594†38,888208,760†(198,316)†
Change in Other Working Capital0†(7,500)——
Net Cash from Operating Activities(48,666)†(46,243)—(43,704)†
Net Cash Provided by (Used In) Operating Activities30,773†(11,289)287,576†(159,186)†
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Used in Investing Activities——(2)†0†
CASH FLOWS FROM FINANCING ACTIVITIES:
Net Cash from Financing Activities(1,158)†249——
Repayments of notes payable——(24,765)†—
Net Cash Provided by (Used in) Financing Activities(38,071)†249(246,424)†75,331†
NET DECREASE IN CASH(7,298)†(11,040)—(83,855)†
CASH AT BEGINNING OF PERIOD10,04521,0858,88992,742
CASH AT END OF PERIOD2,74710,04521,0858,889

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.